Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Langel

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Neuropeptides|February 13, 2001
Galanin receptor subtypes and ligand bindingA Florén, T Land, U Langel
CNS & Neurological Disorders Drug Targets|June 22, 2006
Galanin/GALP receptors and CNS homeostatic processesJ K Robinson, T Bartfai, U Langel
Letters in Applied Microbiology|October 26, 2011
Cell-penetrating peptides as antifungals towards Malassezia sympodialisT Holm, J Bruchmann, A Scheynius, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1992
Lipid-protein interactions in neurotropic Na-pump regulationJ Laasik, R Sillard, U Langel, et al.
Trends in Pharmacological Sciences|February 26, 2000
Cell-penetrating peptidesM Lindgren, M Hällbrink, A Prochiantz, et al.
Biochemistry|March 22, 2001
Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMRM Lindberg, J Jarvet, U Langel, et al.
Biomolecular Engineering|May 5, 2001
PNA oligomers as tools for specific modulation of gene expressionM Pooga, T Land, T Bartfai, et al.
Neuropeptides|December 9, 1998
Purification of a galanin degrading 70 kDa metallo-peptidase from bovine spinal cordA Juréus, M Lindgren, U Langel, et al.
Regulatory Peptides|August 31, 1994
N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse isletsS Gregersen, U Langel, T Bartfai, et al.
British Journal of Pharmacology|April 1, 1994
Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor typesU Kahl, U Langel, T Bartfai, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Neuropeptides|February 13, 2001
Galanin receptor subtypes and ligand bindingA Florén, T Land, U Langel
CNS & Neurological Disorders Drug Targets|June 22, 2006
Galanin/GALP receptors and CNS homeostatic processesJ K Robinson, T Bartfai, U Langel
Letters in Applied Microbiology|October 26, 2011
Cell-penetrating peptides as antifungals towards Malassezia sympodialisT Holm, J Bruchmann, A Scheynius, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1992
Lipid-protein interactions in neurotropic Na-pump regulationJ Laasik, R Sillard, U Langel, et al.
Trends in Pharmacological Sciences|February 26, 2000
Cell-penetrating peptidesM Lindgren, M Hällbrink, A Prochiantz, et al.
Biochemistry|March 22, 2001
Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMRM Lindberg, J Jarvet, U Langel, et al.
Biomolecular Engineering|May 5, 2001
PNA oligomers as tools for specific modulation of gene expressionM Pooga, T Land, T Bartfai, et al.
Neuropeptides|December 9, 1998
Purification of a galanin degrading 70 kDa metallo-peptidase from bovine spinal cordA Juréus, M Lindgren, U Langel, et al.
Regulatory Peptides|August 31, 1994
N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse isletsS Gregersen, U Langel, T Bartfai, et al.
British Journal of Pharmacology|April 1, 1994
Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor typesU Kahl, U Langel, T Bartfai, et al.
Pageof 11